Literature DB >> 26928245

Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?

F Alonzo1, C Melodelima2, F Bratan3, T Vitry4, S Crouzet5, A Gelet5, O Rouvière6.   

Abstract

OBJECTIVE: The goal of this study was to assess the added value of dynamic contrast-enhanced (DCE) imaging in detecting locally radio-recurrent prostate cancer using multiparametric magnetic resonance imaging (mpMRI) at 3Tesla (T).
MATERIALS AND METHODS: We retrospectively analyzed 45 patients with rising prostate-specific antigen level after prostate radiotherapy who underwent mpMRI [T2-weighted (T2w), diffusion-weighted (Dw) and DCE imaging] at 3T before prostate biopsy. Four readers assigned a 5-level Likert score of cancer likelihood in 8 prostate sectors (6 sextants, 2 seminal vesicles) on T2w+Dw and T2w+Dw+DCE images. Biopsy results were used as the standard of reference.
RESULTS: T2w+Dw and T2w+Dw+DCE imaging had similar areas under the receiver operating characteristic curves on per-sector (0.87-0.89 vs. 0.87-0.89; P=0.19-0.78) and per-lobe (0.82-0.94 vs. 0.80-0.91; P=0.21-0.84) analysis. Using a Likert score≥2/5 for diagnosis threshold, T2w+Dw+DCE imaging showed non-significantly higher sensitivities on per-sector (0.56-0.72 vs. 0.52-0.73, P=0.34-0.69) and per-lobe (0.80-0.90 vs. 0.73-0.88; P=0.63-0.99) analysis. It also showed non-significantly lower specificities on per-sector (0.74-0.89 vs. 0.82-0.89; P=0.09-0.99) and per-lobe (0.48-0.81 vs. 0.61-0.84; P=0.10-0.99) analysis. Weighted kappa values were respectively 0.57-0.70 and 0.55-0.66 for T2w+Dw and T2w+Dw+DCE imaging at the sector level, and 0.66-0.83 and 0.58-0.85 at the lobe level.
CONCLUSION: The use of DCE MR imaging tends to increase sensitivity and decrease specificity for all readers, but the differences are not significant.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Dynamic contrast-enhanced MRI; Multiparametric MRI; Neoplasm recurrence; Prostatic neoplasms; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 26928245     DOI: 10.1016/j.diii.2016.01.008

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  6 in total

1.  The value of multimodality imaging in the investigation of a PSA recurrence after radical prostatectomy in the Irish hospital setting.

Authors:  L C McLoughlin; S Inder; D Moran; C O'Rourke; R P Manecksha; T H Lynch
Journal:  Ir J Med Sci       Date:  2017-06-13       Impact factor: 1.568

Review 2.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

3.  Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?

Authors:  Raïssa Lotte; Alexandre Lafourcade; Pierre Mozer; Pierre Conort; Eric Barret; Eva Comperat; Malek Ezziane; Paul-Hugo Jouve de Guibert; Sebastian Tavolaro; Lisa Belin; Franck Boudghene; Olivier Lucidarme; Raphaële Renard-Penna
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

4.  Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.

Authors:  Jie-Ying Kowa; Neil Soneji; S Aslam Sohaib; Erik Mayer; Stephen Hazell; Nicholas Butterfield; Joshua Shur; Derfel Ap Dafydd
Journal:  Br J Radiol       Date:  2021-02-15       Impact factor: 3.039

Review 5.  Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d'Urologie.

Authors:  Paul Sargos; Stéphane Supiot; Gilles Créhange; Gaëlle Fromont-Hankard; Eric Barret; Jean-Baptiste Beauval; Laurent Brureau; Charles Dariane; Gaëlle Fiard; Mathieu Gauthé; Romain Mathieu; Guilhem Roubaud; Alain Ruffion; Raphaële Renard-Penna; Yann Neuzillet; Morgan Rouprêt; Guillaume Ploussard
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

Review 6.  Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers.

Authors:  Alexandru Mihai Nicolae; Niranjan Venugopal; Ananth Ravi
Journal:  Cancer Nanotechnol       Date:  2016-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.